Cited 9 times in
Intravitreal Bevacizumab for the Treatment of Optic Disc Edema in a Patient with POEMS Syndrome
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김도욱 | - |
dc.contributor.author | 김찬윤 | - |
dc.contributor.author | 배형원 | - |
dc.contributor.author | 성공제 | - |
dc.contributor.author | 홍사민 | - |
dc.date.accessioned | 2018-03-26T17:12:45Z | - |
dc.date.available | 2018-03-26T17:12:45Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 1011-8942 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/157350 | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | KJO | - |
dc.relation.isPartOf | Korean Journal of Ophthalmology | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Angiogenesis Inhibitors/administration & dosage | - |
dc.subject.MESH | Bevacizumab/administration & dosage* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Fluorescein Angiography | - |
dc.subject.MESH | Follow-Up Studies | - |
dc.subject.MESH | Fundus Oculi | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Intravitreal Injections | - |
dc.subject.MESH | Optic Disk/pathology* | - |
dc.subject.MESH | POEMS Syndrome/complications* | - |
dc.subject.MESH | POEMS Syndrome/diagnosis | - |
dc.subject.MESH | Papilledema/diagnosis | - |
dc.subject.MESH | Papilledema/drug therapy* | - |
dc.subject.MESH | Papilledema/etiology | - |
dc.title | Intravitreal Bevacizumab for the Treatment of Optic Disc Edema in a Patient with POEMS Syndrome | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Ophthalmology | - |
dc.contributor.googleauthor | Do Wook Kim | - |
dc.contributor.googleauthor | Sung Yong Kang | - |
dc.contributor.googleauthor | Hyoung Won Bae | - |
dc.contributor.googleauthor | Samin Hong | - |
dc.contributor.googleauthor | Gong Je Seong | - |
dc.contributor.googleauthor | Chan Yun Kim | - |
dc.identifier.doi | 10.3341/kjo.2015.29.5.354 | - |
dc.contributor.localId | A04518 | - |
dc.contributor.localId | A01035 | - |
dc.contributor.localId | A01814 | - |
dc.contributor.localId | A01946 | - |
dc.contributor.localId | A04395 | - |
dc.relation.journalcode | J02931 | - |
dc.identifier.eissn | 2092-9382 | - |
dc.identifier.pmid | 26457044 | - |
dc.subject.keyword | Adult | - |
dc.subject.keyword | Angiogenesis Inhibitors/administration & dosage | - |
dc.subject.keyword | Bevacizumab/administration & dosage* | - |
dc.subject.keyword | Female | - |
dc.subject.keyword | Fluorescein Angiography | - |
dc.subject.keyword | Follow-Up Studies | - |
dc.subject.keyword | Fundus Oculi | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Intravitreal Injections | - |
dc.subject.keyword | Optic Disk/pathology* | - |
dc.subject.keyword | POEMS Syndrome/complications* | - |
dc.subject.keyword | POEMS Syndrome/diagnosis | - |
dc.subject.keyword | Papilledema/diagnosis | - |
dc.subject.keyword | Papilledema/drug therapy* | - |
dc.subject.keyword | Papilledema/etiology | - |
dc.contributor.alternativeName | Kim, Do Wook | - |
dc.contributor.alternativeName | Kim, Chan Yun | - |
dc.contributor.alternativeName | Bae, Hyoung Won | - |
dc.contributor.alternativeName | Seong, Gong Je | - |
dc.contributor.alternativeName | Hong, Sa Min | - |
dc.contributor.affiliatedAuthor | Kim, Do Wook | - |
dc.contributor.affiliatedAuthor | Kim, Chan Yun | - |
dc.contributor.affiliatedAuthor | Bae, Hyoung Won | - |
dc.contributor.affiliatedAuthor | Seong, Gong Je | - |
dc.contributor.affiliatedAuthor | Hong, Sa Min | - |
dc.citation.volume | 29 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 354 | - |
dc.citation.endPage | 356 | - |
dc.identifier.bibliographicCitation | Korean Journal of Ophthalmology, Vol.29(5) : 354-356, 2015 | - |
dc.identifier.rimsid | 42382 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.